No Data
No Data
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer
BriaCell Therapeutics Corp: INTERIM MDA EN
BriaCell Therapeutics Corp: INTERIM FINANCIAL STATEMENTSREPORT EN
BriaCell Therapeutics Reports Continued Financial Challenges
10-Q: Q2 2025 Earnings Report